Can This Migraine Concern Rally Further?

Free Report: Join & FOLLOW Biotech Maven

To access this free report, Click 'Join the Conversation' button below and 'Follow' the Biotech Maven.

Several of our followers on SeekingAlpha.com have asked about this small-cap name of late, so here is a ‘deep dive’ on this concern and the findings are published in this free report.

Biohaven Pharmaceuticals (BHVN)

Can This Migraine Concern Rally Further?

Biohaven Pharmaceuticals (BHVN) is a New Haven, Connecticut based clinical-stage biotech that was founded in 2013. The firm came public late in the first half of 2017 and currently sports a market capitalization of just north of $1.5 billion. The stock has made a nice recent run and is trading above its debut level.

Free Report: Biotech Maven

Highly Recommend: To learn about advanced option strategies, watch a free 7 minute video and report by Jay Soloff. Jay, a renowned Options Trading Expert, has been teaching about and using option strategies successfully for two decades. This is a highly recommended tool to add to your investing 'toolbox'. Click here for access to Options Income Blueprint: 3 Proven Strategies to Earn More Cash Today

Comments